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Frequency-dependent acceleration of relaxation
in mammalian heart: a property not relying
on phospholamban and SERCA2a phosphorylation
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An increase in stimulation frequency causes an acceleration of myocardial relaxation
(FDAR). Several mechanisms have been postulated to explain this effect, among which is
the Ca2+–calmodulin-dependent protein kinase (CaMKII)-dependent phosphorylation of the
Thr17 site of phospholamban (PLN). To gain further insights into the mechanisms of FDAR,
we studied the FDAR and the phosphorylation of PLN residues in perfused rat hearts, cat
papillary muscles and isolated cat myocytes. This allowed us to sweep over a wide range of
frequencies, in species with either positive or negative force–frequency relationships, as well
as to explore the FDAR under isometric (or isovolumic) and isotonic conditions. Results
were compared with those produced by isoprenaline, an intervention known to accelerate
relaxation (IDAR) via PLN phosphorylation. While IDAR occurs tightly associated with a
significant increase in the phosphorylation of Ser16 and Thr17 of PLN, FDAR occurs without
significant changes in the phosphorylation of PLN residues in the intact heart and cat papillary
muscles. Moreover, in intact hearts, FDAR was not associated with any significant change in
the CaMKII-dependent phosphorylation of sarcoplasmic/endoplasmic Ca2+ ATPase
(SERCA2a), and was not affected by the presence of the CaMKII inhibitor, KN-93. In isolated
myocytes, FDAR occurred associated with an increase in Thr17 phosphorylation. However, for a
similar relaxant effect produced by isoprenaline, the phosphorylation of PLN (Ser16 and Thr17)
was significantly higher in the presence of the β-agonist. Moreover, the time course of Thr17
phosphorylation was significantly delayed with respect to the onset of FDAR. In contrast, the
time course of Ser16 phosphorylation, the first residue that becomes phosphorylated with iso-
prenaline, was temporally associated with IDAR. Furthermore, KN-93 significantly decreased
the phosphorylation of Thr17 that was evoked by increasing the stimulation frequency, but failed
to affect FDAR. Taken together, the results provide direct evidence indicating that CaMKII
phosphorylation pathways are not involved in FDAR and that FDAR and IDAR do not share
a common underlying mechanism. More likely, a CaMKII-independent mechanism could be
involved, whereby increasing stimulation frequency would disrupt the SERCA2a–PLN inter-
action, leading to an increase in SR Ca2+ uptake and myocardial relaxation.
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The contraction frequency is a fundamental physio-
logical modulator of myocardial function. When the rate
of stimulation increases, there is normally an increase
in contractility (positive force–frequency relationship).
Although this is true for most mammalian species, rats and
mice often show a flat or even negative force–frequency
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response. Moreover, lack of a positive force–frequency
relationship is also found in the failing myocardium.
Regardless of whether the force–frequency relationship is
positive or negative, an increase in stimulation frequency
is always associated with an acceleration of relaxation
(frequency-dependent acceleration of relaxation, FDAR;
Bers, 2000). This mechanism ensures the proper relaxation
and diastolic filling of the ventricle at the higher rates.
Schouten (1990) first hypothesized that the relaxant effect
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of increasing stimulation frequency could be dependent
on the activation of Ca2+–calmodulin-dependent protein
kinase (CaMKII) produced by an increase in Ca2+
cycling and phosphorylation of the sarcoplasmic
reticulum (SR) protein, phospholamban (PLN). Two
main findings converge to support this attractive
hypothesis. First, the prerequisites for sustained CaMKII
activation seem to be specifically met by the increase
in stimulation frequency. In an already classical study,
De Koninck & Schulman (1998) elegantly showed that
CaMKII can decode the frequency of Ca2+ spikes into
distinct amounts of kinase activity. Second, it has been
shown that FDAR is dependent on the SR in different
types of preparations and under different experimental
conditions (Schouten, 1990; Bassani et al. 1995; Hussain
et al. 1997). Since the main regulator of the SR Ca2+ uptake
by sarcoplasmic/endoplasmic Ca2+ ATPase (SERCA2a)
is PLN, and the Thr17 site of PLN is specifically
phosphorylated by CaMKII, PLN and the phosphorylation
of its Thr17 site seems to be the natural candidate to
explain FDAR, as suggested by Schouten (1990). However,
the agreement regarding the first and second points
mentioned above turned to controversy when either the
dependence of CaMKII and/or the involvement of PLN
were directly tested. While experiments from Bassani
et al. (1995) and De Santiago et al. (2002) showed that
FDAR is dependent on CaMKII activation and those
from Hagemann et al. (2000) seemed to indicate that
phosphorylation of the Thr17 residue of PLN is responsible
for FDAR, other experiments failed to detect either an
FDAR dependence on CaMKII activation (Hussain et al.
1997; Layland & Kentish, 1999; Kassiri et al. 2000) or a
significant increase in PLN phosphorylation (Hussain et al.
1997). Experiments in hearts from transgenic animals with
ablation of PLN did not help to clarify the controversy.
Results from Li et al. (1998) and De Santiago et al.
(2002) indicated that FDAR, although dependent on
CaMKII activity, was not dependent on PLN, whereas
results from Bluhm et al. (2000), and more recently
from Champion et al. (2003) and Zhao et al. (2004),
indicated that PLN did play a role in FDAR. Taken
together, the possible participation of CaMKII-dependent
Thr17 phosphorylation in the FDAR phenomenon is
controversial and the underlying mechanisms of FDAR
remain poorly understood.
The aim of the present study was to re-explore
the mechanisms of FDAR using two different
approaches. First, since the main mechanism of the
isoprenaline-dependent acceleration of relaxation
(IDAR) is the increase in PLN phosphorylation
residues (Lindemann et al. 1983; Vittone et al. 1990;
Mundiña-Weilenmann et al. 1996; Said et al. 2002), we
aimed to compare the degree of PLN phosphorylation
residues for a similar FDAR and IDAR. Second, we also
aimed to compare the time course of the development
of FDAR and IDAR with that of Ser16 and Thr17
phosphorylation of PLN. To these purposes three
different preparations were used: isolated perfused rat
hearts; cat papillary muscles; and cat myocytes. The
different preparations allowed us to sweep over a wide
range of frequencies, in species with either positive or
negative force–frequency relationships, as well as to
explore the FDAR under isometric (or isovolumic) and
isotonic conditions.
Methods
Animal studies conformed to the guidelines for Animal
Care of the Scientific Committee of the University of
La Plata, School of Medicine and the Guide for the
Care and Use of Laboratory Animals (NIH Publication
no. 85-23, revised 1996). Cats (1–1.5 kg) and male Wistar
rats (200–300 g) were anaesthetized by intraperitoneal
injection of sodium pentobarbitone (3.5 and 14 mg
(100 g body weight)−1, respectively). Once anaesthetized,
the chest was opened and the heart was removed for
experimental use.
Mechanical studies
Rat heart perfusion. Isolated rat hearts were perfused
according to the Langendorff technique at constant
temperature (37◦C) and flow (12–14 ml min−1), as
previously described (Mundiña-Weilenmann et al. 1996;
Vittone et al. 1998). The composition of the physiological
salt solution (PSS) was (mm): 128.3 NaCl, 4.7 KCl, 1.35
CaCl2, 20.2 NaHCO3, 0.4 NaH2PO4, 1.1 MgCl2, 11.1
glucose and 0.04 Na2EDTA; this solution was equilibrated
with 95% O2–5% CO2 to give a pH of 7.4. To prevent
interference from atrial beats on the electrical pacing,
total heart blockade was performed by crushing the atrial
septum. After this blockade, hearts were paced at different
frequencies (Results). The mechanical activity of the heart
was assessed by passing into the left ventricle a latex
balloon connected to a pressure transducer (Perceptor DT,
Namic, Glen Falls, NY, USA). The balloon was filled with
aqueous solution to achieve a left ventricular end-diastolic
pressure of approximately 10 mmHg.
Cat papillary muscles. One or two papillary muscles were
dissected from the right ventricle of a cat heart and
mounted vertically in a chamber to contract isometrically.
The muscles were stretched until they reached the length
at which maximal developed tension (DT) occurred and
then allowed to stabilize for 1 h at a constant frequency
(30 pulses min−1) and temperature (30◦C) as previously
described (Pedroni et al. 1990; Salas et al. 2001). Muscles
were superfused with the same PSS as described above.
Isolation of cat myocytes. Myocytes were isolated
according to the technique previously described
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(Vila-Petroff et al. 2003). Briefly, excised cat hearts
were mounted on a Langendorff perfusion apparatus.
For enzymatic cell isolation, 118 units ml−1 collagenase
type B (Worthington Biochemical Corp., Lakewood, NJ,
USA) and 0.1 mg ml−1 pronase (Boerhinger Mannheim
Corp., GmbH, Mannheim, Germany), were used.
Perfusion solutions were similar to the PSS buffer
described above, except that bicarbonate was replaced
by 10 mm Hepes, pH adjusted to 7.4 (with NaOH)
and the solution was continuously equilibrated with
100% O2. The concentration of Ca2+ varied along the
different steps in the isolation procedure. After enzymatic
treatment, disaggregated myocytes were separated from
the undigested tissue, rinsed several times with a Hepes
solution containing 1% BSA and 500 µm CaCl2 and
kept in this solution at room temperature until use.
Rod-shaped myocytes with clear and distinct striations
and an obvious marked shortening and relaxation on
stimulation were used. The experiments were performed
at room temperature.
Indo-1 fluorescence and cell shortening measurements.
Isolated myocytes were loaded with the cell-permeant
acetomethyl ester form of indo-1 (17 µm for 9 min)
according to the bulk method described by Spurgeon
et al. (1990) and as we previously described (Vila-Petroff
et al. 2003). Cells were placed on the stage of an
inverted microscope (Nikon Diaphot 200) adapted for
epifluorescence. Myocytes were continuously superfused
at a constant flow (1 ml min−1) and field stimulated
via two platinum electrodes on either side of the bath
(square waves, 2 ms duration and 20% above threshold).
The excitation light was centred at 350 nm and the
fluorescence emitted by the cell was recorded at 410 and
482 nm. Background fluorescence was subtracted from
each signal before obtaining the 410:482 fluorescence
ratio. Diastolic fluorescence ratio was measured as the
mean value over a 100 ms period after the twitch was
completed. Systolic fluorescence ratio was determined
directly from the peak of the recorded ratio. Resting cell
length and cell shortening were measured by a video-based
motion detector (Crescent Electronics, Sandy, UT, USA)
and stored by software for an off-line analysis. For
phosphorylation studies an aliquot of the isolated myocyte
suspension was placed on the stage of an optical micro-
scope and field stimulated at room temperature. Laemmli
sample buffer was added to terminate the experiment.
Biochemical assays
Preparation of rat heart SR membranes. Rat SR
membrane vesicles were prepared as previously described
(Mundiña-Weilenmann et al. 1996). Briefly, the pulverized
ventricular tissue was homogenized in six volumes of
homogenization buffer containing (mm): 5 Na2EDTA,
25 NaF, 300 sucrose, 1 phenylmethanesulphonyl fluoride
(PMSF), 1 benzamidine and 30 KH2PO4. The homo-
genate was centrifuged twice at 14 000 and 16 000g for
20 min. The resulting supernatant was centrifuged at
45 000g for 45 min. The pellet obtained was suspended
in three volumes of buffer containing (mm): 10 Na2EDTA,
25 NaF, 600 KCl, and 50 KH2PO4, and re-centrifuged as
in the previous step. The resulting pellet was suspended in
10 mm Na2EDTA, 10 mm NaF, 250 mm sucrose and 30 mm
histidine.
Papillary muscles. Papillary muscles, pooled to
get approximately 20 mg, were homogenized in
250 µl of a buffer containing (mm): 50 Na4P2O7,
50 NaF, 50 NaCl, 5 Na2EDTA, 5 EGTA, 0.1
Na3VO4, 10 Hepes, 1 PMSF, 1 benzamidine and
0.5 µg ml−1 N-(trans-epoxysuccinyl)-l-leucine
4-guanidinobutylamide (E-64), with a Teflon pestle
and centrifuged at 11 500g for 20 min at 4◦C. The
supernatant was used for phosphorylation studies.
Solutions in the homogenization and membrane
isolation procedure were pH 7.0 at 4◦C. In all preparations,
protein concentration was measured by the method of
Bradford using bovine serum albumin as standard.
Electrophoresis and Western blot analysis. For immuno-
logical detection of PLN phosphorylation sites, 20–30 µg
of SR membrane proteins, homogenized papillary muscles
or myocyte suspension were electrophoresed per gel lane
in a 10% SDS polyacrylamide gel, as previously described
(Mundiña-Weilenmann et al. 1996). Proteins were then
transferred to Immobilon-P polyvinylidene difluoride
(PVDF) membranes and probed with the phosphorylation
site-specific phosphorylated PSer16 and PThr17 PLN anti-
bodies (1:5000; Badrilla, Leeds, UK). Immunoreactivity
was visualized by peroxidase-conjugated antibodies using
a peroxidase-based chemiluminescence detection kit
(Amersham Bioscience). The signal intensity of the bands
on the film was quantified using Scion Image software
(based on NIH Image). Unless otherwise indicated,
phosphorylation results are expressed as percentage of
maximal Ser16 and Thr17 phosphorylation induced by
isoprenaline, run in parallel. In additional experiments,
50 µg of SR membranes proteins were resolved in 8%
acrylamide gels according to Laemmli. Proteins were
transferred and probed with antiserum specific antibody
for the Ca2+-ATPase peptide phosphorylated on Ser38,
SERCA PS-38 (1:5000). As a positive standard, 0.1–2 pmol
of a peptide containing the phosphorylated Ser38 site
of SERCA2a, constructed as described by Rodriguez
et al. (2004), was used. Both the antibody and
the phosphopeptide were kindly provided by J. Colyer
(University of Leeds, UK). Immunoreactivity was
visualized as described above.
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Back phosphorylation. Thirty micrograms of SR
membranes, isolated as described above from hearts
submitted to different frequencies, were phosphorylated
in 50 µl of a reaction medium containing 50 mm
Hepes (pH 7.4), 10 mm MgCl2, 0.1 mm EGTA, 2 µm
calmodulin and 0.1 mm CaCl2. The reaction was
initiated by the addition of 50 µm [γ -32P]ATP, specific
activity 1000–1600 counts min−1 pmol−1, following
preincubation of the rest of the assay components for
3 min at 30◦C. The reaction was terminated after 5 min
by the addition of SDS sample buffer, and the samples
were subjected to SDS-PAGE in a 5–15% gradient gel.
The gels were stained with Comassie Blue, dried and
autoradiographed. 32Phosphorus incorporation into the
specific bands was quantified by analysing the signal
intensity of the bands as described for the Western blot.
Phosphorylation results were expressed as a percentage of
the signal obtained at 120 beats min−1.
Statistics
Data are expressed as means ± s.e.m. Statistical
significance was determined by Student’s t test for
paired and unpaired observations, as appropriate. A
P value < 0.05 was considered statistically significant.
Figure 1. Frequency-dependent acceleration of relaxation (FDAR) depends on a functional sarcoplasmic
reticulum (SR)
A, records of left ventricular developed pressure (LVDP) obtained from a perfused rat heart. The increase of the
contraction frequency produced a decrease in LVDP (negative staircase). B, normalized records of LVDP showing
that this force–frequency relationship is associated with an accelerated relaxation. C, inhibition of SR function with
the treatment of 0.5 µM ryanodine (Ry) plus 2 µM thapsigargin (Thaps) produced a negative inotropic effect at
both stimulation frequencies and suppressed both the negative staircase observed in A and FDAR. D, normalized
records of LVDP to illustrate better the suppression of FDAR in the presence of Ry and Thaps. E, bars show the ratio
between the time to half-relaxation (t1/2 ) at the high and low frequencies (FDAR index) obtained in the absence
(Control) or the presence of an inhibited SR (Ry + Thaps). Inhibition of SR function abolished the decrease of
the ratio below 1 that was produced by FDAR. Results are expressed as means ± S.E.M. of n = 4–6 experiments.
∗ P < 0.05 with respect a ratio of 1; ∗∗ P < 0.05 with respect to control.
Results
FDAR is dependent on SR
Several previous studies indicate that the SR is involved
in the relaxant effect of increasing contraction frequency
(FDAR; Schouten, 1990; Bassani et al. 1995; Hussain
et al. 1997). Experiments were performed to confirm
this issue in our experimental conditions. Figure 1 shows
typical records of the left ventricular developed pressure
(LVDP) of a perfused rat heart. The increase in contraction
frequency from 60 to 120 beats min−1 decreased LVDP
(negative staircase, Fig. 1A). This negative inotropic effect
was associated with a FDAR, which is better appreciated
in the normalized records of Fig. 1B. Perfusion with
ryanodine and thapsigargin, to functionally block the
SR, abolished the FDAR as shown in the original and
normalized records of Fig. 1C and D, respectively. The
low range of the force–frequency relationship explored in
these experiments was due to the fact that higher, more
physiological frequencies for the rat, cause contracture
of the hearts in the absence of a functional SR. As an
additional index of FDAR, we used the ratio between the
half-relaxation time (t 1/2 ) at the high and the low frequency
studied (t 1/2 at 120 beats min
−1/t 1/2 at 60 beats min
−1;
Fig. 1E; De Santiago et al. 2002). A significant decrease of
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Figure 2. Effects of increasing contraction frequency (A) and isoprenaline (B) on relaxation and
phosphorylation of Ser16 and Thr17 residues of PLN in the perfused rat heart
The increase in the contraction frequency from 120 to 510 beats min−1 produced a decrease in t1/2 (¥ in A) similar
to that induced by increasing isoprenaline from 0.3 to 300 nM (¥ in B). While the relaxant effect of isoprenaline
was associated with the enhancement of the phosphorylation of both PLN residues, the increase in the contraction
frequency did not modify PLN phosphorylation either at Ser16 ( ) or Thr17 (•) residues. Results are expressed as
means ± S.E.M. of n = 4–12 experiments; t1/2 is expressed as change (1ms) with respect to 120 beats min−1 (A) or
the absence of drug (B). ∗ P < 0.05 with respect to 120 beats min−1 (A) or the absence of drug (B).
this index below a ratio of 1 is indicative of FDAR. It can be
seen that in the absence of ryanodine and thapsigargin, the
increase in the stimulation frequency reduced the FDAR
index to 0.86 ± 0.04, n = 4 (P < 0.05), whereas in the
presence of these drugs, FDAR was abolished. Thus, it
seems undoubted that the underlying mechanism of FDAR
either resides at the SR level or at least needs a functionally
intact SR.
Does Thr17 of PLN participate in the FDAR?
Figure 2 illustrates the relaxant effect and the average
PLN phosphorylation at Ser16 and Thr17 sites, observed
with incremental heart rates (Fig. 2A) and isoprenaline
concentrations (Fig. 2B) in the perfused rat heart. Both
the FDAR and the isoprenaline-dependent acceleration
of relaxation (IDAR) were similar, as indicated by the
reduction of t 1/2 . However, while increasing stimulation
frequency from 120 to 510 beats min−1 failed to increase
the phosphorylation of Ser16 and Thr17 of PLN, addition
of isoprenaline from 0.3 to 300 nm produced a significant
increase in the phosphorylation of both PLN residues.
Similar results were obtained in another multicellular
preparation of a different species, the cat papillary
muscle. Again, while the relaxant effect of 1 µm iso-
prenaline was associated with a significant increase in the
phosphorylation of Ser16 and Thr17 residues of PLN, no
significant changes in the phosphorylation of both residues
were observed, for a similar relaxant effect produced by
raising stimulation frequency from 10 to 60 beats min−1
(Fig. 3).
In a further attempt to search for the underlying
mechanisms of FDAR, we compared the effect of elevating
contraction frequency in the absence and the presence
of the β-agonist in the perfused rat heart (Fig. 4A). At
each stimulation frequency, the presence of 30 nm iso-
prenaline produced a further decrease in t 1/2 . However,
both curves were parallel and the FDAR index did
not reveal any differences between the values measured
in the absence and the presence of the β-agonist (t 1/2
at 510 beats min−1/t 1/2 at 120 beats min
−1 = 0.59 ± 0.02
and 0.54 ± 0.06, respectively, Fig. 4B). We next tested
the variation of heart rate at a maximal iso-
prenaline stimulation (300 nm, Fig. 4C). At this maximal
concentration, stimulation frequency was increased from
120 to 590 beats min−1. At a fixed stimulation
Figure 3. Phosphorylation of Ser16 and Thr17 residues of PLN at
a similar relaxant effect produced by either increasing
contraction frequency or addition of appropriate isoprenaline
concentration in cat papillary muscles
A similar decrease of t1/2 was obtained when cat papillary muscles
stimulated at 10 beats min−1 were then stimulated at 60 beats min−1
or perfused with 1 µM isoprenaline. Only the relaxant effect produced
by the β-agonist was associated with enhancement of PLN
phosphorylation at the Ser16 and Thr17 residues. Phosphorylation of
Ser16 and Thr17 residues was maximal at this concentration of
isoprenaline. Results are expressed as means ± S.E.M. of n = 6–13
experiments. ∗ P < 0.05 with respect to 1 µM isoprenaline.
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frequency of 120 beats min−1, isoprenaline produced a
concentration-dependent increase in the relaxant effect.
At a maximal isoprenaline concentration (300 nm), an
abrupt change to 510 beats min−1 in the continuous
presence of the β-agonist produced a further decrease in
t 1/2 that was not associated with any additional increase in
the phosphorylation of PLN sites (Fig. 4D).
Taken together, the results in multicellular preparations
argue in favour of the hypothesis that IDAR and FDAR
are supported by different mechanisms: while IDAR
occurs tightly associated with the phosphorylation of
PLN residues, FDAR occurs in the absence of any
significant increase in the phosphorylation of PLN sites.
Figure 4. Do FDAR and IDAR share a common mechanism?
A and B illustrate the effects of β-adrenergic stimulation on FDAR. A, rat hearts were stimulated at increasing
frequencies in the absence (Control) and in the presence of 30 nM isoprenaline (Iso). A similar decrease of t1/2 to that
induced by increasing contraction frequency from 120 to 510 beats min−1 was attained in the absence and in the
presence of the β-agonist. B, the lack of action of isoprenaline upon FDAR was also detected in the ratio between
t1/2 at 510 and 120 beats min
−1. The significant decrease of this ratio below 1 was not different between control
and isoprenaline-stimulated hearts. Results are expressed as means ± S.E.M. of n = 5–12 experiments. ∗ P < 0.05
with respect to a ratio of 1. C and D illustrate the effects of the enhancement of contraction frequency on
IDAR. C, hearts, stimulated at 120 beats min−1, were perfused with increasing isoprenaline concentrations. At the
maximal concentration-dependent relaxant effect of isoprenaline (300 nM), increasing the contraction frequency to
510 beats min−1 produced an additional decrease in t1/2 . D, phosphorylation levels of the Ser
16 and Thr17 residues
of PLN induced by 300 nM isoprenaline were not modified by a change in stimulation frequency from 120 to
510 beats min−1. Results are expressed as means ± S.E.M. of n = 4 experiments.
Is SERCA2a the target of the CaMKII activation
induced by increasing stimulation frequency
responsible of FDAR?
The results presented so far are compelling evidence
indicating the lack of any important physiological
role of PLN in the FDAR phenomenon. To test the
possible participation of other CaMKII substrates in the
FDAR, the status of phosphorylation of SERCA2a, the
major alternative candidate, was explored. Figure 5A
shows a typical autoradiogram and overall results of
the phosphorylation of SERCA2a, studied by the back
phosphorylation technique in perfused rat hearts,
C° The Physiological Society 2004
J Physiol 562.3 Mechanisms of frequency-dependent acceleration of cardiac relaxation 807
at two different stimulation frequencies, 120 and
510 beats min−1. The back phosphorylation method
shows the mirror phosphorylation image of the actual
in vivo phosphorylation. Phosphorylation of SERCA2a
was the same at the two frequencies explored. Moreover,
and in agreement with the experiments performed with
site-specific phosphorylation antibodies (Fig. 2A), no
significant changes in the phosphorylation of PLN were
observed. Similar results were obtained in the presence
and absence of added exogenous CaMKII, which would
indicate that possible variations in the CaMKII activity in
the different experimental situations are not responsible
for the results obtained. In an additional group of
experiments, we used a recently described polyclonal
antibody specific for the phosphorylated Ser38 peptide
of SERCA2a (Rodriguez et al. 2004) to evaluate the
phosphorylation of SERCA2a in SR membrane vesicles
isolated from hearts contracting at 120 and
510 beats min−1. The immunoblot of Fig. 5B shows
that no significant phosphorylation of SERCA2a could
be detected in these membrane preparations, in spite
of the high immunodetection sensitivity of the assay
(0.5 pmol of the phosphopeptide used for calibration,
see Methods). Assuming that SERCA2a is 10% of total
SR protein (Hawkins et al. 1994), 50 pmol SERCA2a
should be expected in 50 µg of SR protein loaded per gel
lane. The lack of detection of SERCA2a phosphorylation
would indicate that, if phosphorylation occurred, it
would result in the generation of less than 1% of Ser38
phosphoprotein.
Figure 5. Effect of stimulation frequency on CaMKII phosphorylation of SR membranes
A, SR membranes isolated from perfused rat hearts stimulated at 120 and 510 beats min−1 were back
phosphorylated with the endogenous CaMKII and [γ -32P]-ATP. Left panel, autoradiogram; right panel, overall
results, expressed as means ± S.E.M. of n = 9 experiments. Note that the in situ treatment (frequency change) did
not alter the ability of SERCA2a and PLN to serve as substrate for the in vitro phosphorylation. B, immunoblot of
SR membranes probed with SERCA PS-38 antibody. The antibody did not detect any significant phosphorylation
of SERCA2a in SR membranes, although it was able to recognize the phosphoepitope peptide conjugated to a
scaffolding protein (calibration standard, Cal-38) run in parallel.
Effects of CaMKII inhibition on FDAR
In a further attempt to study the possible involvement of
the CaMKII-dependent phosphorylations in the FDAR,
we performed experiments with the specific CaMKII
inhibitor, KN-93. Since KN-93 is unable to inhibit the
autophosphorylated form of CaMKII (Tokumitsu et al.
1990), hearts were perfused with 5 µm of the inhibitor
in the presence of low extracellular Ca2+ (0.25 mm) for
10 min, to diminish Ca2+ entry to the cell and allow
for dephosphorylation of the enzyme (Bassani et al.
1995). Increasing the stimulation frequency from 120
to 510 beats min−1 decreased t 1/2 by 20.10 ± 2.83 ms and
the time constant of the Ca2+ transient decay (τ ) by
7.40 ± 2.52 ms (n = 5) in the absence of KN-93. In
the presence of the inhibitor, t 1/2 and τ decreased by
17.60 ± 3.31 and 5.10 ± 4.11 ms, respectively (n = 5). Of
note, despite the lack of effect of KN-93 on relaxation,
the CaMKII inhibitor produced a significant enhancement
of the negative staircase observed in the perfused rat
heart. Raising the stimulation frequency from 120 to
510 beats min−1 diminished LVDP by 38.83 ± 2.39 and
76.28 ± 2.93% in the absence and presence, respectively,
of KN-93. This negative inotropic effect may be the
consequence of KN-93 inhibition of L-type Ca2+ current
(especially at higher frequencies), or ryanodyne receptor
gating (Li et al. 1997). These results indicate that the failure
of KN-93 to significantly impair FDAR is not due to either
an inadequate concentration of KN-93 or to the protocol
of administration of the inhibitor.
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Phosphorylation of Thr17 of PLN in myocytes
The lack of detection of any significant increase in
PLN phosphorylation after increasing the stimulation
frequency in multicellular preparations is hard to
reconcile with the findings of Hagemann et al. (2000),
who reported a close association between FDAR and
the phosphorylation of Thr17 of PLN in isolated rat
myocytes. To examine whether the cause of the
discrepant results resides in the different preparations
used, we performed experiments in isolated cat myocytes.
Stimulation frequencies ranging from 10 to 60 beats min−1
produced an FDAR, indexed by the decrease in the
time from the peak to half of the Ca2+ transient
decline (t 1/2 transient), and a significant increase in the
phosphorylation of Thr17 at faster stimulation rates,
independently of that of Ser16 (Fig. 6A). Figure 6B shows
that the frequency-dependent abbreviation of the t 1/2
Figure 6. Effects of increasing contraction frequency on
relaxation and phosphorylation of Ser16 and Thr17 residues of
PLN in cat myocytes
A, average data of isolated cat myocytes stimulated for 3 min at
increasing frequencies. The decrease in the half-relaxation time of the
Ca2+ transient (t1/2 transient, ¥) was associated with an increase in the
phosphorylation of Thr17 (•) independently of that of Ser16 ( ),
detected as in Fig. 2. B, correlation between Thr17 phosphorylation
and t1/2 .t1/2 is expressed as change (1ms) with respect to
10 beats min−1. Results are expressed as means ± S.E.M. of n = 4–9
experiments.
transient tightly correlates with the frequency-dependent
increase in Thr17 phosphorylation. However, when the
degree of PLN phosphorylation obtained at the maximal
FDAR was compared with the isoprenaline-induced PLN
phosphorylation at a similar relaxant effect, the latter
intervention (3 nm isoprenaline) significantly enhanced
the phosphorylation of both PLN residues (49.1 ± 7.8
and 56.6 ± 16.6%, n = 7, above basal values for Ser16 and
Thr17, respectively), whereas the increase in stimulation
frequency only enhanced the phosphorylation of Thr17
site by 29.6 ± 7.2%, n = 9, without modifications in the
phosphorylation of Ser16 (Fig. 7).
To investigate whether Thr17 phosphorylation of PLN
can account at least in part for the rate-dependent
abbreviation of the t 1/2 transient in myocytes, we studied
the time course of the appearance of the FDAR and Thr17
phosphorylation (Fig. 8A). As early as in the second beat
(2.5 s) after the frequency step (from 10 to 50 beats min−1),
the t 1/2 transient was significantly decreased, reaching
its lowest value. However, phosphorylation of PLN
at the Thr17 residue significantly increased 15 s after
the frequency change. Thus, phosphorylation of Thr17
occurred at a slower rate than the FDAR, arguing
against the participation of PLN phosphorylation in the
determination of this effect. In contrast, the onset of
IDAR was temporally associated with the increase in
the phosphorylation of Ser16 (Fig. 8B). Phosphorylation
of Thr17 became significant only after 2 min of
isoprenaline administration (66.0 ± 15.3%). This increase
was associated with a further enhancement of IDAR,
Figure 7. Phosphorylation of Ser16 and Thr17 residues of PLN at
a similar relaxant effect produced by either increasing
contraction frequency or increasing isoprenaline concentration
in cat myocytes
A similar decrease in t1/2 transient was obtained when isolated cat
myocytes were either submitted to a frequency change from 10 to
60 beats min−1 or superfused with 3 nM isoprenaline. While IDAR and
FDAR were associated with a significant increase in the
phosphorylation of Thr17, IDAR was also associated with a significant
increase in the phosphorylation of Ser16. Results are expressed as
means ± S.E.M. of n = 8–10 experiments. ∗ P < 0.05 with respect to
10 beats min−1.
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which occurred in the absence of any significant increase
in the phosphorylation of Ser16. The time-delayed Thr17
phosphorylation is consistent with former results in rat
and guinea-pig hearts (Wegener et al. 1989; Kuschel
et al. 1999) and might indicate that the PKA-dependent
increase in intracellular Ca2+ is not large enough at the
very beginning of isoprenaline administration to activate
CaMKII (Said et al. 2002).
Figure 9 shows the results of a group of experiments
in which we studied the effects of inhibiting Thr17
phosphorylation with the specific inhibitor of CaMKII,
KN-93, on the FDAR. Although 1 µm KN-93 inhibited
the frequency-dependent increase in the phosphorylation
of Thr17, the decrease in half-relaxation time (t 1/2 ) and
the time constant of the Ca2+ transient decay (τ )
associated with a frequency step from 10 to 50 beats min−1,
was not different in the presence and in the absence
of the CaMKII inhibitor. Another CaMKII inhibitor
(autocamtide-2 related inhibitory peptide, AIP, 10 µm)
also failed to diminish the relaxant effect of the increase
in contraction frequency. Thus, even in a preparation
in which the increase in stimulation frequency increases
the phosphorylation of the Thr17 site of PLN, this
phosphorylation cannot explain the FDAR.
Figure 8. Time course of relaxation and phosphorylation of PLN residues during an increase in
stimulation frequency and administration of isoprenaline in cat myocytes
A, upper panel shows a representative immunoblot of Thr17 PLN phosphorylation during an increase in stimulation
frequency from 10 to 50 beasts min−1. Lower panel shows the average data of Thr17 PLN phosphorylation
(n = 5 for each data point, •) and of the decrease in t1/2 transient (n = 3) for the same frequency step. The
decrease in t1/2 transient (¥) became significant 2.5 s after the change of frequency, while phosphorylation of Thr
17
occurred more slowly. B, upper panel shows a representative immunoblot of Ser16 and Thr17 phosphorylation
during administration of 30 nM isoprenaline. Lower panel shows the average data of Ser16 ( ) and Thr17 (•)
PLN phosphorylation (n = 5 for each data point) and of the decrease in t1/2 transient (n = 6, ¥) for the same
isoprenaline concentration. The phosphorylation of Ser16 of PLN occurred temporally associated with the onset
of IDAR. Phosphorylation of Thr17 attained significant levels after 2 min of isoprenaline administration and was
associated with a further enhancement of IDAR. ∗ P < 0.05 with respect to the phosphorylation of Ser16 or Thr17
at 10 beats min−1 (A) and before isoprenaline administration (B). †P < 0.05 with respect to the t1/2 value at
10 beats min−1 (A) and before isoprenaline administration (B).
Discussion
Although the FDAR phenomenon has been explored
in several laboratories, the conflicting results obtained
in the different studies conspire against a complete
understanding of the underlying mechanisms involved.
The aim of the present study was to gain further
insight into the comprehension of these mechanisms. The
use of different species and preparations allowed us to
explore a wide range of stimulation frequencies under
various experimental conditions, i.e. isometric or isotonic
contractions, different temperatures, and even different
inotropic response to the increase in stimulation
frequency.
Our major finding is that the phosphorylation of
PLN residues does not participate in FDAR and that
FDAR and IDAR should be explained by different
mechanisms. While IDAR occurs closely associated with a
significant increase in PLN phosphorylation, no significant
increases in the phosphorylation of Thr17 residue of PLN,
the site that would be expected to be phosphorylated
by increasing stimulation frequency, could be detected
associated with FDAR in the perfused rat heart and in
cat papillary muscles (Figs 2 and 3). Furthermore, the
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increase in stimulation frequency produced a similar
and parallel relaxant effect when hearts were perfused
in the presence and the absence of a high isoprenaline
concentration, without any significant increase in the level
of PLN phosphorylation above the value observed at the
lowest frequency (Fig. 4). Although FDAR was associated
with an increase in Thr17 phosphorylation in isolated
myocytes, this increase occurred after the maximal FDAR
was reached (Fig. 8). In contrast, the increase in the
phosphorylation of the Ser16 residue of PLN, the first
site that becomes phosphorylated upon isoprenaline
administration, was temporally associated with a relaxant
effect. This relaxant effect was further enhanced when
phosphorylation of Thr17 site attained significant levels.
These results clearly indicate that FDAR is not dependent
on the phosphorylation of Thr17, and that IDAR and FDAR
do not share any common underlying mechanism. In
addition, FDAR occurs in the absence of any detectable
increase in SERCA2a phosphorylation (Fig. 5).
Figure 9. Effects of CaMKII inhibition on the relaxation and Thr17 phosphorylation induced by a
frequency step from 10 to 50 beats min−1
A, representative immunoblot of Ser16 PLN phosphorylation (PSer16-PLN) and Thr17 PLN phosphorylation
(PThr17-PLN) at 10 and 50 beats min−1 in the absence and the presence of 1 µM KN-93 to inhibit CaMKII. Inhibition
of CaMKII reduced the phosphorylation of Thr17 attained at 50 beats min−1. B, bars show the overall results
(n = 6–9 experiments). C and D, the diminished Thr17 phosphorylation did not occur associated with either a
reduction in t1/2 or in the time constant of the Ca
2+ transient decline (τ ). Results are expressed as means ± S.E.M.
of n = 6–10 experiments. ∗ P < 0.05 with respect to 10 beats min−1.
In the intact ventricle, activation of CaMKII and
inhibition of PP1, the phosphatase that dephosphorylates
PLN, have been shown to be necessary conditions
for detection of the phosphorylation of Thr17 of PLN
(Mundiña-Weilenmann et al. 1996; Vittone et al. 1998;
Said et al. 2002). These prerequisites are achieved after
β-adrenoceptor stimulation, in which the activation of
PKA increases intracellular calcium (by phosphorylation
of the Ser16 residue of PLN and L-type Ca2+ channels;
Tsien et al. 1986; Mundiña-Weilenmann et al. 1996) and
inhibits PP1 (Cohen & Cohen, 1989; Gupta et al. 2002), or
by mimicking these conditions by increasing extracellular
calcium in the presence of either acidic pH or okadaic
acid, to inhibit PP1 (Mundiña-Weilenmann et al. 1996;
Vittone et al. 1998; Said et al. 2002). Indeed, we have
previously shown that increasing extracellular calcium,
which by itself failed to increase the phosphorylation
of Thr17, significantly increased the phosphorylation
of this residue in the presence of either high
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isoprenaline concentrations or phosphatase inhibitors
(Mundiña-Weilenmann et al. 1996; Vittone et al. 1998;
Said et al. 2002). In the present experiments, it was shown
that the increase in stimulation frequency did not further
increase the phosphorylation of Thr17, even in the presence
of a high isoprenaline concentration. These results would
indicate that the increase in contraction frequency either
failed to enhance CaMKII activation above that evoked
by isoprenaline or produced an increase in phosphatase
activity that would counteract the β-agonist-induced
phosphatase inhibition. The latter possibility seems
unlikely, however, since Ser16 phosphorylation was not
decreased by the increase in stimulation frequency. In
any case, our results demonstrated that the increase in
frequency produced a pronounced and significant relaxant
effect, under conditions in which the hearts already
showed an accelerated relaxation owing to the presence of
isoprenaline and in the absence of any significant change
in Thr17 phosphorylation.
The present experiments also showed, however, that in
isolated myocytes, FDAR was associated with an increase
in Thr17 phosphorylation. This finding is in agreement
with the experiments of Hagemann et al. (2000), which
showed a good correlation between the phosphorylation of
Thr17 and FDAR. However, a good correlation coefficient
does not necessarily imply a causal relationship. We
showed that the increase in PLN phosphorylation observed
with FDAR, i.e. Ser16 and Thr17 sites, was significantly
lower than that associated with IDAR, for the same
relaxant effect. More importantly, the CaMKII-induced
phosphorylation of the Thr17 site of PLN observed in
the intact myocytes was temporally dissociated from
the relaxant effect of increasing stimulation frequency.
As further support for the lack of participation of
Thr17 phosphorylation on FDAR, specific inhibition of
CaMKII by KN-93 failed to affect FDAR. Thus, our
results do not support the conclusion of Hagemann et al.
(2000), in the sense that the relaxant effect of increasing
stimulation frequency was determined by the degree of
Thr17 phosphorylation.
The cause of the contradictory findings that Thr17
was phosphorylated by increasing stimulation frequency
in isolated myocytes but not in the perfused rat heart
or the papillary muscle is not apparent to us. The
degree of phosphorylation of any protein depends on the
balance between the activities of kinases and phosphatases
involved in this particular phosphorylation. The increase
in the phosphorylation of Thr17 of PLN in the isolated
myocytes associated with FDAR, as opposed to the
lack of phosphorylation in the intact heart and
the papillary muscles, may indicate either a higher
CaMKII activity or a lower phosphatase activity in
the isolated myocytes compared with the multicellular
preparations. Although we did not explore these
possibilities, it is tempting to speculate that the lower
temperature used in the experiments with isolated
myocytes may produce a relatively higher inhibition of
phosphatases than of CaMKII, leading to the necessary
imbalance responsible for the increase in phosphorylation
of Thr17 observed in isolated myocytes. Evidence
suggesting a higher inactivation of phosphatases relative to
kinases has been found in both intact and permeabilized
rat myocytes (Mattiazzi et al. 1994; Bassani et al. 1995),
working also at low temperature.
Experiments from Narayanan’s group (Xu et al. 1993;
Xu & Narayanan, 1999; 2000) were the first to describe a
direct CaMKII-dependent phosphorylation of SERCA2a.
This phosphorylation, occurring at Ser38, resulted in
activation of the V max of Ca2+ transport (Xu et al. 1993;
Toyofuku et al. 1994; Xu & Narayanan, 1999). Other
results, however, argue against this finding. While Reddy
et al. (1996) failed to demonstrate a CaMKII-dependent
phosphorylation of SERCA2a, Odermatt et al. (1996) did
show a significant increase in Ser38 phosphorylation that
was, however, not associated with any significant change
in the activity of SERCA2a. The present experiments
failed to demonstrate any significant increase in SERCA2a
phosphorylation from increasing stimulation frequency.
A possible source of error to be considered is that
the lack of SERCA2a phosphorylation with increasing
stimulation frequency might arise from the fact that the
phosphorylation of a single residue in a huge protein,
although present, cannot be detected with the method
used. However, in agreement with previous findings
(Rodriguez et al. 2004), phosphorylation of the Ser38
residue of SERCA2a was also undetected when using
a sensitive specific antibody raised against this site. In
addition, the fact that KN-93 failed to affect FDAR both
in intact myocytes and perfused hearts would further
support the contention that the CaMKII-dependent
phosphorylation of SERCA2a is not involved in the
FDAR.
The lack of dependence of FDAR on CaMKII shown in
the present results is in agreement with previous findings
(Hussain et al. 1997; Layland & Kentish, 1999; Kassiri
et al. 2000). In contrast, other experiments were able to
demonstrate a CaMKII dependence of FDAR (Bassani et al.
1995; Li et al. 1997, 1998; De Santiago et al. 2002). The
cause of these opposite results is not readily apparent.
The different experimental protocols (steady state versus
post-rest contractions) used in some of these previous
studies (Bassani et al. 1995; Li et al. 1997, 1998) could
be partly responsible for the discrepant results. This issue,
however, requires further investigation.
Kimura et al. (1997) first proposed that elevated
Ca2+, by itself, enhances the PLN–SERCA2a heterodimer
dissociation, thereby increasing SERCA2a activity. More
recent experiments from the same group further showed
that high Ca2+ disrupts the physical interaction between
PLN and SERCA2a in HEK cells, overexpressing SERCA2a
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and PLN (Asahi et al. 2000). Although it is difficult to
explore this model in vivo, it is tempting to speculate
that FDAR can be explained by a direct effect of high
intracellular Ca2+ on the interaction between PLN and
SERCA2a, a possibility that does not require CaMKII
activation.
In any case, our results provided direct evidence
indicating that the FDAR phenomenon is not dependent
on the phosphorylation of any of the two main proteins
involved in the SR calcium uptake. The results show in
addition that IDAR and FDAR do not share a common
underlying mechanism.
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